NDC 24338-080-25 - OTOVEL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24338-080
- Requested NDC
- 24338-080-25
- Package NDCs from labels
- 24338-080-25, 24338-080-14
- Manufacturer
- Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation
- Effective date
- 2019-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OTOVEL - Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation | Arbor Pharmaceuticals | Laboratorios Salvat | The Ritedose Corporation | 2019-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24338-080-14 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-ec5a-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use OTOVEL safely and effectively. See full prescribing information for OTOVEL. OTOVEL (ciprofloxacin and fluocinolone acetonide) otic solution Initial U.S. Approval: 2016 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24338-080-14 | OTOVEL | 14 in 1 POUCH | SOLUTION | 14 | 3 | |
| 24338-080-14 | OTOVEL | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 24338-080-25 | OTOVEL | 0.25 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 0.25 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optimel Manuka Dry Eye Drops | GLYCERIN | Melcare Biomedical Pty Ltd | 88c5e2f0-9f7e-62d1-e053-2995a90a9014 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Optimel Manuka Forte Eye Gel | GLYCERIN | Melcare Biomedical Pty Ltd | 8e0ed6e8-51fc-7c5b-e053-2a95a90a35a9 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Fluocinolone Acetonide Oil | FLUOCINOLONE ACETONIDE | Rising Pharma Holdings, Inc. | 79591576-1eab-48c5-b0a6-e205b3cc097e | 2026-03-09 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide Oil | FLUOCINOLONE ACETONIDE | Rising Pharma Holdings, Inc. | f45b0ef2-1702-4d21-8ac8-774769304595 | 2026-03-09 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 4c6094b7-c1ef-26a3-e063-6394a90af4cc | 2026-03-06 | Warnings | PDC6A3C0OX |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | PDC6A3C0OX |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX 6OZP39ZG8H |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| fluocinolone acetonide | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | 50e7006d-a51b-49aa-8e1c-330340e7bf82 | 2026-02-23 | Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | 622c9804-0be0-4dec-a6ba-5cf4b5578a84 | 2026-02-23 | Adverse reactions | 0CD5FD6S2M |
| YUTIQ | FLUOCINOLONE ACETONIDE | ANI Pharmaceuticals, Inc. | f270cad8-ed82-4969-b785-831a1910bfa6 | 2026-02-19 | Warnings, Adverse reactions | 0CD5FD6S2M |
| Fluocinolone Acetonide Topical Solution USP, 0.01% | FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% | Bryant Ranch Prepack | 3fa4d5db-b17f-44dc-aa6a-50934d42c68d | 2026-02-18 | Adverse reactions | 0CD5FD6S2M |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.